当前位置: 首页 > 详情页

RNA processing genes characterize RNA splicing and further stratify lower-grade glioma

文献详情

资源类型:

收录情况: ◇ SCIE

机构: [1]Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. [2]Chinese Glioma Genome Atlas, Beijing, China. [3]China National Clinical Research Center for Neurological Diseases and [4]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
出处:
ISSN:

摘要:
BACKGROUND. Aberrant expression of RNA processing genes may drive the alterative RNA profile in lower-grade gliomas (LGGs). Thus, we aimed to further stratify LGGs based on the expression of RNA processing genes. METHODS. This study included 446 LGGs from The Cancer Genome Atlas (training set) and 171 LGGs from the Chinese Glioma Genome Atlas (validation set). The least absolute shrinkage and selection operator (LASSO) Cox regression algorithm was conducted to develop a risk signature. The receiver operating characteristic curves and Kaplan-Meier curves were used to study the prognostic value of the risk signature. RESULTS. Among the tested 784 RNA processing genes, 276 were significantly correlated with the overall survival of LGGs. Further LASSO Cox regression identified a 19-gene risk signature, whose risk score was also an independent prognosis factor (P < 0.0001, multiplex Cox regression) in the validation data set. The signature had better prognostic value than the traditional factors "age," "grade," and "WHO 2016 classification" for 3 - and 5 year survival both data sets (AUCs >85%). Importantly, the risk signature could further stratify the survival of LGGs in specific subgroups of WHO 2016 classification. Furthermore, alternative splicing events for genes such as EGFR and FGFR were found to be associated with the risk score. mRNA expression levels for genes, which participated in cell proliferation and other processes, were significantly correlated to the risk score. CONCLUSIONS. Our results highlight the role of RNA processing genes for further stratifying the survival of patients with LGGs and provide insight into the alternative splicing events underlying this role.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 医学:研究与实验
JCR分区:
出版当年[2017]版:
最新[2023]版:
Q1 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. [2]Chinese Glioma Genome Atlas, Beijing, China. [3]China National Clinical Research Center for Neurological Diseases and
共同第一作者:
通讯作者:
通讯机构: [1]Department of Molecular Neuropathology, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. [2]Chinese Glioma Genome Atlas, Beijing, China. [3]China National Clinical Research Center for Neurological Diseases and [4]Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing, China. [*1]Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Number 119 South Fourth Ring West Road, Beijing 100070, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16461 今日访问量:0 总访问量:871 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院